What this study is
Based on our current understanding of Aicardi syndrome, the condition is hypothesized to occur due to a genetic change on the X-chromosome. The research team is investigating Aicardi syndrome to identify the specific gene location associated with the disorder. The investigators are collecting blood and skin biopsy samples from patients and their parents. A permanent cell line is prepared and DNA from the blood and skin samples and cell lines is isolated and then used for genetic testing. The current research includes microarray analysis which which is used to look for duplications or deletions of genetic material, mutation analysis of candidate genes by sequencing, genome-wide sequencing, review of medical records to identify trends suggesting possible candidate genes of interest, and X chromosome inactivation studies.
What's being tested
- Syndrome cause identification
Intervention · OTHER
Study details
- Official title
- Pathogenesis of Selected X-Linked Dominant Disorders and New Strategies to Identify the Gene Mutated in Aicardi Syndrome
- Sponsor
- Baylor College of Medicine
- Conditions
- Aicardi Syndrome · Brain Disorders
- Enrolling
- 500 people
- Starts
- 2002-10
- Est. completion
- 2030-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Features suggestive of Aicardi syndrome (not all features must be present)
- Agenesis of the corpus callosum
- Chorioretinal lacunae
- Seizures (infantile spasms)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openBaylor College of Medicine
Houston, Texas, United States
- Ignatia B Van den Veyver, MD · Contact832-824-8125iveyver@bcm.edu
- Ignatia B Van den Veyver, MD · Principal investigator
Recruiting
Study team
Sponsor
Baylor College of Medicine
Study ID BCM Aicardi H12791
Principal investigator
Ignatia B Van den Veyver, MD
Baylor College of Medicine
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.